reports
Jeffs’ Brands Enters the Logistics Center Market by Closing Strategic ...
Jeffs’ Brands Enters the Logistics Center Market by Closing Strategic Acquisition of a U.S. Company that Operates a U.S. Based Logistics Center Jeffs’ Brands Announces the closing of a $2.6 Million Acquisition of a company operating an approx. 100,000-square-foot logistics facility with 20 loading docks near a major U.S. port, aiming to strengthen its supply chain and third-party service offerings Tel Aviv, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Market...
374Water Announces its AirSCWO Technology is Successful in Eliminating...
374Water Announces its AirSCWO Technology is Successful in Eliminating LNAPL-Based PFAS from Impacted Groundwater Samples from the U.S. Navy Results Underscore the Robustness of AirSCWO Technology in Eliminating PFAS and Transforming Complex Waste Streams DURHAM, N.C., March 18, 2025 (GLOBE NEWSWIRE) -- 374Water Inc. (NASDAQ: SCWO) ("374Water") (the "Company"), a global leader in waste destruction technology for the municipal, federal, and industrial markets, today announced the successful treatment and destruction of Light Non-Aqueous Phase Liquid (LNAPL) impacted with Per- and Polyfl...
Expion360 to Host Fourth Quarter and Full Year 2024 Financial Results ...
Expion360 to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on Monday, March 31, 2025 at 4:30 p.m. Eastern Time REDMOND, Ore., March 18, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: XPON) (the “Company”), an industry leader in lithium-ion battery power storage, will hold a conference call on Monday, March 31, 2025, at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and full year ended December 31, 2024, and review ongoing initiatives and anticipated 2025 milestones. A press release detailing these results will be issued prior to the call. ...
CSW Industrials Announces Definitive Agreement to Acquire Aspen Manufa...
CSW Industrials Announces Definitive Agreement to Acquire Aspen Manufacturing for $313.5 Million, Executing Disciplined Capital Allocation and Strategic Expansion in the HVAC/R End Market Aspen Manufacturing Acquisition Highlights Continues the expansion of existing product portfolio in the profitable heating, ventilation, air conditioning, and refrigeration (HVAC/R) end market with the addition of evaporative coils and air handler offeringsAligns with previously established acquisition criteria to leverage existing distribution channels, increase our market share in HVAC/R end market, exp...
Swiss Re to sell 10.05% stake in Definity Financial for CAD 655 millio...
Swiss Re to sell 10.05% stake in Definity Financial for CAD 655 million ZURICH, March 18, 2025 (GLOBE NEWSWIRE) -- Swiss Re announced an agreement to sell 11,647,217 common shares ("Common Shares") of Definity Financial Corp. (TSX: DFY) ("Definity") representing approximately 10.05% of the issued and outstanding Common Shares as of March 17, 2025 (the "Offering"). The Common Shares are being sold by Swiss Re Investment Holdings Company Ltd on an underwritten block trade basis at a price of CAD 56.20 per Common Share for aggregate cash proceeds of approximately CAD 655 million. The Offeri...
New Research Unveils Key Success Factors for Retailers in Unified Comm...
ATLANTA--(BUSINESS WIRE)-- (NASDAQ: MANH), today announced the findings of the . Co-sponsored by and conducted by , the study assessed 220 North America retailers across 300+ capabilities spanning four key experience areas: Shopping, Checkout, Fulfillment, and Service. Based on real-world purchases, returns, and customer interactions across digital and physical channels, the Benchmark identifies key traits of top-performing retailers and uncovers opportunities for brands to enhance customer value and modernize operations. Among the retailers assessed, only 5% achieved Leader status, demonst...
Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License A...
Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva® Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”) and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has accepted a 351(k) Biologic License Application (BLA) submission for AVT03, developed by ...
March 2025 Letter to Shareholders
March 2025 Letter to Shareholders VANCOUVER, Washington, March 18, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, As envisioned, 2025 is unfolding to be an exciting year for CytoDyn Inc. (“CytoDyn” or the “Company”). On February 24, 2025, the Company announced increased survival rates in patients with metastatic Triple-Negative Breast Cancer (“mTNBC”) who were treated with leronlimab in prior CytoDyn-sponsored studies. The impressive survival observations at 12, 24, and 36 months in patients who previously failed treatment in the metastatic or locally advanced setting indicate leronlimab ...
TransGlobal Assets Inc. (OTC: TMSH) Names Michael Berman as CEO
TransGlobal Assets Inc. (OTC: TMSH) Names Michael Berman as CEO New CEO to Drive Growth in AI-Powered Mental Health, Wellness & Performance Analytics Key Highlights: TransGlobal Assets Inc. (OTC: TMSH) Appoints Michael Berman as CEOFollowing the acquisition of Mindwell Solutions Group LLC, TransGlobal Assets names tech visionary Michael Berman as CEO to drive AI-powered mental health, relationship wellness, and performance analytics innovation.Expansion into AI-Powered Emotional Intelligence & Biometric AnalysisWith proprietary AI-driven technologies, TransGlobal aims to revolutionize ...
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c...
NEW YORK--(BUSINESS WIRE)-- Schrödinger, Inc. (Nasdaq: SDGR) today reported that on March 15, 2025, the company granted (i) a non-statutory stock option to purchase 1,575 shares of the company’s common stock to one newly hired employee and (ii) restricted stock units (RSUs) with respect to 6,943 shares of the company’s common stock to seven newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company’s board of directors, and were made ...
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharm...
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference HANOVER, Md., March 18, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and safety, today announced its participation in the MedInvest Biotech and Pharma Investor Conference being held March 27-28, 2025, at Cooley’s law office in New York City. Management will present a corporate overview on Friday, March 28th at 9:40 a.m. Easte...
Matvæla- og lyfjaeftirlit Bandaríkjanna (FDA) samþykkir að taka til af...
Matvæla- og lyfjaeftirlit Bandaríkjanna (FDA) samþykkir að taka til afgreiðslu umsókn um markaðsleyfi fyrir AVT03, fyrirhugaða hliðstæðu við Prolia og Xgeva Alvotech (NASDAQ: ALVO) og samstarfsaðili þess, alþjóðlega lyfjafyrirtækið Dr. Reddy‘s Laboratories Ltd. („Dr. Reddy‘s“) tilkynntu í dag að Matvæla- og lyfjaeftirlit Bandaríkjanna (FDA) hafi samþykkt að taka til afgreiðslu umsókn um markaðsleyfi fyrir AVT03, fyrirhugaða líftæknilyfjahliðstæðu við Prolia og Xgeva, sem bæði innihalda virka efnið denosumab. „Samþykki FDA á því að taka umsókn um markaðsleyfi fyrir denosumab-hliðstæðuna til...
Palvella Therapeutics to Host Full Year 2024 Financial Results Confere...
Palvella Therapeutics to Host Full Year 2024 Financial Results Conference Call on March 31, 2025 WAYNE, Pa., March 18, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies, today announced that it will report its full year 2024 financial results on Monday, March 31, 2025. Palvella management will host a conference call for investors at 8:30 a.m. ET on Monday, March 31, 2025, ...
CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Re...
CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025 BERKELEY HEIGHTS, N.J., March 18, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2024, before the market opens on Tuesday, March 25, 2025, and will host a corporate update conference call at 8:30am Eastern Time. Tuesday, Ma...
IDT Corporation to Present at Sidoti Investor Conference
IDT Corporation to Present at Sidoti Investor Conference NEWARK, NJ, March 18, 2025 (GLOBE NEWSWIRE) -- IDT Corporation (NYSE: IDT), a global provider of fintech, cloud communications, and traditional communications solutions, will present at the Sidoti Virtual Investor Conference that will be held on March 19th and 20th, 2025. Marcelo Fisher, Chief Financial Officer, will present at 10:45 AM Eastern time on Wednesday, March 19th. His presentation will provide an overview of IDT’s operations, strategy, and financial results. Mr. Fischer will also host one-on-one investor meetings through...
Preferred Bank Announces Approval to Continue Share Repurchase Plan
Preferred Bank Announces Approval to Continue Share Repurchase Plan LOS ANGELES, March 18, 2025 (GLOBE NEWSWIRE) -- Preferred Bank (NASDAQ: PFBC), (“the Bank”), an independent commercial bank, today announced that the Bank has received regulatory approval to continue its shareholder-approved $150 million stock Repurchase Plan, (“the Plan”). Thus far in the Plan, the Bank has repurchased $84.3 million of its common stock during 2023 and 2024, however regulatory approval expired in January of 2025. As a state, non-member Bank that issues its common stock at the bank level (no holding compan...
Blue Hat Completes 1 Ton Gold Purchase, Surging Gold Prices Boost Book...
Blue Hat Completes 1 Ton Gold Purchase, Surging Gold Prices Boost Book Profits to New Highs HONG KONG, March 18, 2025 (GLOBE NEWSWIRE) -- Blue Hat Interactive Entertainment Technology (“Blue Hat” or the “Company”) (NASDAQ: BHAT) has successfully completed the final payment for the gold transaction between its Hong Kong wholly-owned subsidiary, Golden Alpha Strategy Limited, and Macau Rongxin Precious Metals Technology Co., Ltd. According to the agreement, these ordinary shares are subject to a 3-year lock-up period and do not carry voting rights. This arrangement reflects the full tr...
Inspired Entertainment Announces Long-Term Contract Extension with Buz...
Inspired Entertainment Announces Long-Term Contract Extension with Buzz Bingo NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Inspired Entertainment, Inc. (“Inspired” or the “Company”) (NASDAQ: INSE), a leading provider of gaming content, systems, and solutions, is pleased to announce the extension of its partnership with Buzz Bingo, Britain’s leading omni-channel bingo operator. This contract extension marks a significant milestone in the long-standing collaboration between Inspired and Buzz Bingo, ensuring the supply of 500 Category B3 and C terminals across 79 Buzz Bingo venues. This ren...
Prenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing C...
Prenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market Adds Renowned Clinical Experts Dr. Jeremy London and Dr. Amy Shah to Existing Team from Mayo Clinic, Cedars-Sinai, NASA and Yale University CHARLOTTE, N.C., March 18, 2025 (GLOBE NEWSWIRE) -- , the premium supplements brand co-founded by David Beckham, today announced the addition of two distinguished new members, Dr. Jeremy London and Dr. Amy Shah, to its world-class (SAB). These additions underscore IM8’s unwavering commitment to leading innovation in science, lo...
BTCS Inc. to Launch New Partnership with Wharton's Mack Institute
Silver Spring, Maryland--(Newsfile Corp. - March 18, 2025) - (Nasdaq: BTCS) ("BTCS" or the "Company"), a leader in blockchain infrastructure and technology, today announced it is joining the at as a corporate partner. This initiative will be conducted through Wharton's Mack Institute for Innovation Management, the project aims to explore the resilience and scalability of Ethereum, the world's largest smart contract platform. As institutional adoption of Ethereum accelerates-exemplified by BlackRock's $100 million tokenized U.S. Treasuries fund and Tether's role as one of the largest global ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.